Capula Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$26.1K Sell
929
-5,543
-86% -$148K ﹤0.01% 1030
2025
Q4
$161K Sell
6,472
-616
-9% -$15.5K ﹤0.01% 635
2025
Q3
$181K Sell
7,088
-108,303
-94% -$2.67M ﹤0.01% 631
2025
Q2
$2.8M Buy
115,391
+34,670
+43% +$809K 0.03% 105
2025
Q1
$2.05M Buy
80,721
+67,650
+518% +$1.77M 0.01% 194
2024
Q4
$347K Buy
+13,071
New +$355K ﹤0.01% 209
2024
Q3
Sell
-31,931
Closed -$893K 605
2024
Q2
$893K Sell
31,931
-967
-3% -$26.6K 0.01% 164
2024
Q1
$913K Buy
+32,898
New +$913K 0.02% 111
2023
Q4
Sell
-10,594
Closed -$351K 519
2023
Q3
$351K Buy
+10,594
New +$375K 0.01% 421
2023
Q2
Sell
-86,963
Closed -$3.55M 703
2023
Q1
$3.55M Buy
+86,963
New +$3.76M 0.04% 264
2022
Q4
Sell
-8,827
Closed -$423K 862
2022
Q3
$386K Buy
+8,827
New +$429K 0.01% 517
2022
Q2
Sell
-220
Closed -$11.2K 361
2022
Q1
$11K Buy
+220
New +$11.4K ﹤0.01% 275
2021
Q4
Sell
-32,876
Closed -$1.41M 630
2021
Q3
$1.41M Sell
32,876
-22,785
-41% -$1.01M 0.02% 459
2021
Q2
$2.16M Buy
55,661
+44,593
+403% +$1.73M 0.03% 290
2021
Q1
$401K Buy
+11,068
New +$393K 0.01% 400
2020
Q3
Sell
-321,417
Closed -$9.97M 281
2020
Q2
$9.97M Buy
321,417
+171,872
+115% +$5.84M 0.35% 71
2020
Q1
$4.63M Buy
+149,545
New +$5.1M 0.17% 161

Other funds holding PFE

Capula Management's PFE Position: Q1 2026 in Review

Capula Management reduced its Pfizer (PFE) stake by 86% in Q1 2026, selling an estimated $148K and leaving 929 shares worth $26.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1030.

Capula Management first reported a position in PFE in Q1 2020 and has held it in 17 quarters since. The position peaked at $9.97M in Q2 2020. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Capula Management held 929 shares of Pfizer worth $26.1K as of Q1 2026.
  • Capula Management sold 5,543 Pfizer shares in Q1 2026, an estimated $148K.
  • Pfizer made up ﹤0.01% of Capula Management's portfolio in Q1 2026, its #1030 holding.
  • Capula Management first reported a position in Pfizer in Q1 2020 and has held it in 17 quarters since.
  • Capula Management's Pfizer position peaked at $9.97M in Q2 2020.
  • 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Capula Management's 13F filing for Q1 2026, filed 14 May 2026.